Can Caris Life Sciences turn Caris Assure into a broader precision oncology platform?
Caris wants New York access for Caris Assure. The bigger test is whether liquid biopsy scale can satisfy tougher state oversight.
Why Watchmaker Genomics is repurposing CRISPR-Cas9 to reshape NGS library normalization at scale
Watchmaker Genomics is repurposing CRISPR-Cas9 to streamline NGS normalization. Find out why this matters for sequencing at scale.